Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiaki Washio

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|September 9, 2009
Direct small-molecule kinase activation: Novel approaches for a new era of drug discoveryGraham L Simpson, Jennifer A Hughes, Yoshiaki Washio, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysisJun Tang, Lisa M Shewchuk, Hideyuki Sato, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
From PIM1 to PI3Kδ via GSK3β: Target Hopping through the KinomeZoë A Henley, Benjamin D Bax, Laura M Inglesby, et al.
Chemmedchem|June 18, 2019
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 AntagonistsRichard J D Hatley, Tim N Barrett, Robert J Slack, et al.
Journal of Medicinal Chemistry|August 7, 2007
Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptorsMasaichi Hasegawa, Naohiko Nishigaki, Yoshiaki Washio, et al.
Journal of Medicinal Chemistry|September 21, 2020
A Turing Test for Molecular GeneratorsJacob T Bush, Peter Pogany, Stephen D Pickett, et al.
Journal of Computer-Aided Molecular Design|February 28, 2014
Structure-guided optimization of small molecule c-Abl activatorsXuan Hong, Ping Cao, Yoshiaki Washio, et al.
Journal of Medicinal Chemistry|February 20, 2020
DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) InhibitorsWieslaw M Kazmierski, Bing Xia, John Miller, et al.
Journal of Medicinal Chemistry|January 29, 2019
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesGraham L Simpson, Sophie M Bertrand, Jennifer A Borthwick, et al.
Journal of Medicinal Chemistry|August 25, 2015
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory DiseaseKenneth Down, Augustin Amour, Ian R Baldwin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|September 9, 2009
Direct small-molecule kinase activation: Novel approaches for a new era of drug discoveryGraham L Simpson, Jennifer A Hughes, Yoshiaki Washio, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysisJun Tang, Lisa M Shewchuk, Hideyuki Sato, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
From PIM1 to PI3Kδ via GSK3β: Target Hopping through the KinomeZoë A Henley, Benjamin D Bax, Laura M Inglesby, et al.
Chemmedchem|June 18, 2019
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 AntagonistsRichard J D Hatley, Tim N Barrett, Robert J Slack, et al.
Journal of Medicinal Chemistry|August 7, 2007
Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptorsMasaichi Hasegawa, Naohiko Nishigaki, Yoshiaki Washio, et al.
Journal of Medicinal Chemistry|September 21, 2020
A Turing Test for Molecular GeneratorsJacob T Bush, Peter Pogany, Stephen D Pickett, et al.
Journal of Computer-Aided Molecular Design|February 28, 2014
Structure-guided optimization of small molecule c-Abl activatorsXuan Hong, Ping Cao, Yoshiaki Washio, et al.
Journal of Medicinal Chemistry|February 20, 2020
DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) InhibitorsWieslaw M Kazmierski, Bing Xia, John Miller, et al.
Journal of Medicinal Chemistry|January 29, 2019
Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS MethodologiesGraham L Simpson, Sophie M Bertrand, Jennifer A Borthwick, et al.
Journal of Medicinal Chemistry|August 25, 2015
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory DiseaseKenneth Down, Augustin Amour, Ian R Baldwin, et al.
Pageof 2